ventilan oral liquid - Søgeresultater

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

keflor cefaclor 125mg/5ml (as monohydrate) powder for oral liquid bottle

alphapharm pty ltd - cefaclor monohydrate, quantity: 26.22 mg/ml (equivalent: cefaclor, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; erythrosine; sucrose; pregelatinised starch; flavour - keflor is indicated for the treatment of the following types of infections caused by or likely to be caused susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections, including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. keflor appears to be effective as phenoxymethul penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organisms to cefaclor.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

epilim liquid sodium valproate 40 mg/ml sugar free oral liquid bottle

sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: purified water; sorbitol solution (70 per cent) (non-crystallising); sodium methyl hydroxybenzoate; citric acid; brilliant scarlet 4r; hyetellose; sodium propyl hydroxybenzoate; saccharin sodium; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

cafnea oral solution caffeine citrate oral solution 25 mg/5 ml oral administration vial

phebra pty ltd - caffeine, quantity: 12.5 mg - oral liquid, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; water for injections - cafnea oral solution is indicated for the short-term treatment of apnoea of prematurity in infants between 28 and 33 weeks gestational age.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

zantac 150mg/10ml

aspen pharmacare australia pty ltd - ranitidine hydrochloride, quantity: 16.8 mg/ml (equivalent: ranitidine, qty 15 mg/ml) - oral liquid - excipient ingredients: hypromellose; ethanol; sorbitol solution (70 per cent) (non-crystallising); butyl hydroxybenzoate; saccharin sodium; propyl hydroxybenzoate; sodium chloride; dibasic sodium phosphate; monobasic potassium phosphate; purified water; flavour - short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage: maintenance treatment to reduce the risk of relapse in duodenal ulcer: maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer: treatment of gastrinoma (zollinger-ellison syndrome): short-term treatment of severe reflux oesophagitis: treatment of scleroderma oesophagitis. the intravenous injection is indicated where oral treatment is inappropriate. new indications as at 2 november 1993: 1. short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. treatment of gastrinoma (zollinger-ellison syndrom

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

gliolan (aminolevulinic acid hcl) powder for oral solution, 30 mg/ml, vial

specialised therapeutics glio pty ltd - aminolevulinic acid hydrochloride, quantity: 1.5 g - oral liquid, powder for - excipient ingredients: - gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant gliomas that are glioblastoma multiforme (gbm) on preoperative imaging, and who are intended for resection of the tumour.

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

prolet oral liquid for dogs

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

liquid s. klenz heavy duty low foaming chlorinated alkaline detergent

ecolab pty ltd - chlorine present as sodium hypochlorite; sodium hydroxide - liquid - chlorine present as sodium hypochlorite mineral-chlorine active 59.0 g/l; sodium hydroxide mineral-sodium-base active 261.0 g/l - dairy cleanser - dairy equipment stainless steel - deposits (ref. to label for type) | milkstone removal | protein build-up | residue, dirt in milking equipment | fat deposits | milk fat | milk protein | mineral deposits | protein deposits

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nemacur 400 nematicide liquid

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd closantel sustained action oral anthelmintic and flukicide for sheep and lambs

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vincit c seed dressing liquid